These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 2934124)

  • 1. Chemotherapy for advanced pancreatic cancer. A comparison of 5-fluorouracil, adriamycin, and mitomycin (FAM) with 5-fluorouracil, streptozotocin, and mitomycin (FSM).
    Oster MW; Gray R; Panasci L; Perry MC
    Cancer; 1986 Jan; 57(1):29-33. PubMed ID: 2934124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase II studies of drug combinations in advanced pancreatic carcinoma: fluorouracil plus doxorubicin plus mitomycin C and two regimens of streptozotocin plus mitomycin C plus fluorouracil. The Gastrointestinal Tumor Study Group.
    J Clin Oncol; 1986 Dec; 4(12):1794-8. PubMed ID: 2946815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of three chemotherapeutic regimens in the treatment of advanced pancreatic and gastric carcinoma. Fluorouracil vs fluorouracil and doxorubicin vs fluorouracil, doxorubicin, and mitomycin.
    Cullinan SA; Moertel CG; Fleming TR; Rubin JR; Krook JE; Everson LK; Windschitl HE; Twito DI; Marschke RF; Foley JF
    JAMA; 1985 Apr; 253(14):2061-7. PubMed ID: 2579257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A phase III randomized study of 5-fluorouracil and cisplatin versus 5-fluorouracil, doxorubicin, and mitomycin C versus 5-fluorouracil alone in the treatment of advanced gastric cancer.
    Kim NK; Park YS; Heo DS; Suh C; Kim SY; Park KC; Kang YK; Shin DB; Kim HT; Kim HJ
    Cancer; 1993 Jun; 71(12):3813-8. PubMed ID: 8508349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase II trial of 5-fluorouracil, adriamycin, mitomycin C, and streptozotocin (FAM-S) in pancreatic carcinoma.
    Bukowski RM; Schacter LP; Groppe CW; Hewlett JS; Weick JK; Livingston RB
    Cancer; 1982 Jul; 50(2):197-200. PubMed ID: 6211223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MIFA III (mitomycin-C, 5-fluorouracil, and adriamycin) chemotherapy for advanced adenocarcinoma of the pancreas.
    Sternberg CN; Magill GB; Sordillo PP; Cheng EW
    Am J Clin Oncol; 1984 Oct; 7(5):529-33. PubMed ID: 6391145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 5-fluorouracil, Adriamycin, and mitomycin-C (FAM) chemotherapy for advanced adenocarcinoma of the pancreas.
    Smith FP; Hoth DF; Levin B; Karlin DA; MacDonald JS; Woolley PV; Schein PS
    Cancer; 1980 Nov; 46(9):2014-8. PubMed ID: 7427908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 5-fluorouracil, adriamycin, and mitomycin in the treatment of adenocarcinoma of unknown primary.
    Goldberg RM; Smith FP; Ueno W; Ahlgren JD; Schein PS
    J Clin Oncol; 1986 Mar; 4(3):395-9. PubMed ID: 3754004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclophosphamide versus 5-fluorouracil, doxorubicin, and mitomycin C (FAM') in the treatment of hormone-resistant metastatic carcinoma of the prostate: a preliminary report of a randomized trial.
    Kasimis BS; Miller JB; Kaneshiro CA; Forbes KA; Moran EM; Metter GE
    J Clin Oncol; 1985 Mar; 3(3):385-92. PubMed ID: 3838343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized controlled study of mitomycin C/carboquone/5-fluorouracil/OK-432 (MQ-F-OK) therapy and mitomycin C/5-fluorouracil/doxorubicin (FAM) therapy against advanced liver cancer.
    Sakata Y; Komatsu Y; Takagi S; Saitoh S; Itoh T; Suzuki H; Tsushima K; Sasaki D; Yoshida Y
    Cancer Chemother Pharmacol; 1989; 23 Suppl():S9-12. PubMed ID: 2647315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 5-fluorouracil, adriamycin, and mitomycin-C (FAM) chemotherapy in advanced adenocarcinoma of the lung: comparison of two dosage schedules.
    Lam WK; So SY; Kung TM; Sham MK; Ip M
    Cancer Chemother Pharmacol; 1987; 19(3):269-71. PubMed ID: 3107849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 5-Fluorouracil, doxorubicin (adriamycin) and mitomycin-C (FAM) in advanced gastric cancer: observations on response, patient characteristics, myelosuppression and delivered dosage.
    Biran H; Sulkes A; Biran S
    Oncology; 1989; 46(2):83-7. PubMed ID: 2710481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclic combination chemotherapy in advanced adenocarcinoma of the lung: comparison of two FAM schedules.
    Lam WK; So SY; Ip M; Yu DY
    Cancer Chemother Pharmacol; 1985; 14(3):282-3. PubMed ID: 3922641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 5-Fluorouracil, doxorubicin and mitomycin C (FAM) combination chemotherapy for metastatic adenocarcinoma of unknown primary.
    van der Gaast A; Verweij J; Planting AS; Stoter G
    Eur J Cancer Clin Oncol; 1988 Apr; 24(4):765-8. PubMed ID: 3383976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 5-Fluorouracil, adriamycin, and mitomycin-C (FAM) in the treatment of inoperable adenocarcinoma of the lung.
    Shepherd FA; Evans WK; Burkes R; Paul K; DeBoer G
    Am J Clin Oncol; 1986 Oct; 9(5):392-6. PubMed ID: 3776901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 5-Fluorouracil, mitomycin, and doxorubicin (FAM) in carcinoma of the biliary tract.
    Harvey JH; Smith FP; Schein PS
    J Clin Oncol; 1984 Nov; 2(11):1245-8. PubMed ID: 6092556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A phase III comparison trial of streptozotocin, mitomycin, and 5-fluorouracil with cisplatin, cytosine arabinoside, and caffeine in patients with advanced pancreatic carcinoma.
    Kelsen D; Hudis C; Niedzwiecki D; Dougherty J; Casper E; Botet J; Vinciguerra V; Rosenbluth R
    Cancer; 1991 Sep; 68(5):965-9. PubMed ID: 1833042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase II trial of streptozotocin, mitomycin-C and 5-fluorouracil (SMF) in the treatment of advanced pancreatic cancer.
    Wiggans RG; Woolley PV; Macdonald JS; Smythe T; Ueno W; Schein PS
    Cancer; 1978 Feb; 41(2):387-91. PubMed ID: 147131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Further studies on the treatment of advanced gastric cancer by 5-fluorouracil, Adriamycin (doxorubicin), and mitomycin C (modified FAM).
    Haim N; Epelbaum R; Cohen Y; Robinson E
    Cancer; 1984 Nov; 54(9):1999-2002. PubMed ID: 6548173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of advanced gastric carcinoma with 5-fluorouracil adriamycin, and mitomycin C (FAM).
    Haim N; Cohen Y; Honigman J; Robinson E
    Cancer Chemother Pharmacol; 1982; 8(3):277-80. PubMed ID: 6897021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.